- Home
- Automated
- List of product information
- HORGESIC TABLET 35MG/450MG [SIN16415P]
HORGESIC TABLET 35MG/450MG [SIN16415P]
Active ingredients: HORGESIC TABLET 35MG/450MG
Last updated 26 October 2025
On this page
Product Info
HORGESIC TABLET 35MG/450MG
[SIN16415P]
Product information
Active Ingredient and Strength | ORPHENADRINE CITRATE - 35 MG |
Dosage Form | TABLET |
Manufacturer and Country | HOVID BERHAD - MALAYSIA |
Registration Number | SIN16415P |
Licence Holder | GOLDPLUS UNIVERSAL PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | M03BC51 |
Indications
Tension headache, occipital headaches associated with spasm of skeletal muscles in the region of the head and neck. Acute and traumatic conditions of the limbs and trunk: sprains, strains, whiplash injuries, acute torticollis, prolapsed intervertebral disc.
Dosage and Administration
Table caption
Adult | : | Oral, 1 to 2 tablets three to four times daily up to a maximum of 8 tablets per day. |
Children | : | Not recommended in children. |
Note: The information given here is limited. For further information consult your doctor or pharmacist.
Contraindications
Orphenadrine shows some anticholinergic activity and should not be used in patients with glaucoma, prostatic hypertrophy or obstruction at the bladder neck, or myasthenia gravis.